Vimarsana
Biggest News Aggregation in the World

Danforth Advisors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Danforth Advisors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Danforth Advisors Today - Breaking & Trending Today

Aileron Therapeutics : Management Change/Compensation - Form 8-K -March 29, 2024 at 08:05 am EDT - Vimarsana News

Aileron Therapeutics : Management Change/Compensation - Form 8-K -March 29, 2024 at 08:05 am EDT

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;...

S&W Seed Company Appoints Jeffrey Rona to Its Board of Directors - Vimarsana News

S&W Seed Company Appoints Jeffrey Rona to Its Board of Directors

LONGMONT, Colo., Dec. 19, 2023 /PRNewswire/ -- S&W Seed Company , a global agricultural technology company, today announced the nomination of senior biotechnology executive Jeffrey Rona to its Board...

Predictive Oncology Inc. (NASDAQ:POAI) Q2 2023 Earnings Call Transcript - Vimarsana News

Predictive Oncology Inc. (NASDAQ:POAI) Q2 2023 Earnings Call Transcript

Predictive Oncology Inc. (NASDAQ:POAI) Q2 2023 Earnings Call Transcript August 10, 2023 Operator: Good day, and thank you for standing by. Welcome to the Predictive Oncology Q2 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be an opportunity to ask your questions. Please […]

Source: yahoo.com
NLS Pharmaceutics AG: NLS Pharmaceutics Appoints Keith Harrison Dewedoff as Interim Chief Financial Officer - Vimarsana News

NLS Pharmaceutics AG: NLS Pharmaceutics Appoints Keith Harrison Dewedoff as Interim Chief Financial Officer

ZÜRICH, SWITZERLAND / ACCESSWIRE / May 8, 2023 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and

Finch Therapeutics taps Matthew Blischak as CEO, appoints CFO - Vimarsana News

Finch Therapeutics taps Matthew Blischak as CEO, appoints CFO

Incoming CEO Matthew Blischak succeeds Mark Smith, who will remain with the firm as a scientific and strategic advisor.